The Severe Asthma Research Program III-Boston Clinical Site

CompletedOBSERVATIONAL

Enrollment

126

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

March 15, 2020

Study Completion Date

January 15, 2021

Conditions

Asthma

Trial Locations (2)

Boston Children's Hospital, Boston

Brigham and Women's Hospital, Boston

All Listed Sponsors

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Elliot Israel, MD

OTHER

NCT01761630 - The Severe Asthma Research Program III-Boston Clinical Site | Biotech Hunter | Biotech Hunter